| Withdrawn | Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive M NCT04142398 | AIDS Malignancy Consortium | — |
| Withdrawn | Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men NCT04142385 | AIDS Malignancy Consortium | — |
| Not Yet Recruiting | Menopausal HT for Women Living With HIV (HoT) NCT06856174 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 4 |
| Not Yet Recruiting | Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial NCT06708351 | Emory University | N/A |
| Not Yet Recruiting | Baricitinib Curative Repression of HIV-1 NCT07209267 | Emory University | Phase 2 |
| Not Yet Recruiting | "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort" NCT07412977 | ANRS, Emerging Infectious Diseases | — |
| Not Yet Recruiting | Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients NCT07391046 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effec NCT06900829 | Casper Rokx | N/A |
| Recruiting | MAPS PrEP Van Study NCT06908252 | Duke University | Phase 4 |
| Recruiting | MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003) NCT07042945 | Merck Sharp & Dohme LLC | Phase 1 |
| Not Yet Recruiting | HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM) NCT06913959 | ANRS, Emerging Infectious Diseases | — |
| Recruiting | Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Enviro NCT06771843 | San Diego State University | N/A |
| Recruiting | Multiplo Tp/HIV Self-Test NCT06716450 | Unity Health Toronto | N/A |
| Not Yet Recruiting | Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025) NCT06842706 | ANRS, Emerging Infectious Diseases | — |
| Recruiting | Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience NCT07031063 | Instituto Mexicano del Seguro Social | Phase 4 |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Not Yet Recruiting | Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation NCT06830668 | National Center for AIDS/STD Control and Prevention, China CDC | Phase 4 |
| Recruiting | Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527 | AIDS Malignancy Consortium | Phase 1 |
| Not Yet Recruiting | Occult Hepatitis B Virus Infection and HBV Reactivation After Switching to Long Acting Therapy in Patients Wit NCT06728917 | IRCCS San Raffaele | — |
| Recruiting | Zn Supplementation in HIV Immunological Non Responders NCT06612554 | Parc de Salut Mar | N/A |
| Recruiting | Impact of Mediterranean Diet in Cardiovascular Risk Among People With HIV NCT06757309 | Parc de Salut Mar | N/A |
| Completed | UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children NCT05993767 | PENTA Foundation | Phase 2 |
| Recruiting | HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients NCT06659952 | University of Texas Southwestern Medical Center | N/A |
| Completed | Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutane NCT06585891 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Not Yet Recruiting | Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient NCT06587542 | Universitas Padjadjaran | Phase 2 / Phase 3 |
| Recruiting | Good-first: B/F/TAF As First-line ART NCT06619288 | Affiliated Hospital of Nantong University | — |
| Not Yet Recruiting | Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy. NCT06421259 | Centre Hospitalier Universitaire de Nice | — |
| Completed | HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes NCT06671808 | Zahedan University of Medical Sciences | — |
| Unknown | Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam NCT05506475 | Institut Pasteur | — |
| Completed | Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi NCT06200545 | HIV Prevention Trials Network | N/A |
| Recruiting | PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable NCT06807736 | Desmond Tutu HIV Foundation | — |
| Completed | Technology-based Training Tool for PHAT Life NCT05339412 | Oregon Research Behavioral Intervention Strategies, Inc. | N/A |
| Recruiting | Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Em NCT06907056 | José Antonio Mata Marín | Phase 4 |
| Recruiting | Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatmen NCT06676410 | Code Pharma | Phase 2 |
| Recruiting | The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection NCT05652088 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | CASI-Plus mHealth for Ukraine's APS Program (Aim 1) NCT06971120 | University of Washington | — |
| Active Not Recruiting | Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa NCT07006246 | Professor Francois Venter | Phase 4 |
| Active Not Recruiting | A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppr NCT05729568 | Gilead Sciences | Phase 2 |
| Recruiting | Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers NCT05663502 | AIDS Malignancy Consortium | — |
| Withdrawn | The Lymphoid Tissue Pharmacology of Antiretroviral Drugs NCT02707926 | University of Nebraska | — |
| Recruiting | Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living NCT04949464 | AIDS Malignancy Consortium | N/A |
| Active Not Recruiting | A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV- NCT05766501 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Next Generation Ingestible Sensors for Medication Adherence Measurement NCT05592613 | Brigham and Women's Hospital | Phase 3 |
| Unknown | Pathogen Detection in HIV-infected Children With Non-malarial Febrile Illnesses Using Metagenomic Sequencing NCT05085158 | Makerere University | — |
| Recruiting | Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth NCT05965245 | Washington University School of Medicine | N/A |
| Terminated | Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers NCT04083170 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants W NCT04801758 | HIV Vaccine Trials Network | N/A |
| Active Not Recruiting | Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer NCT04929028 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Traditional Healer-initiated HIV Counseling and Testing in South Africa NCT05079347 | Vanderbilt University Medical Center | N/A |
| Withdrawn | Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial NCT04939311 | Priscilla Hsue, MD | Phase 1 / Phase 2 |
| Withdrawn | Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervica NCT03834571 | AIDS Malignancy Consortium | Phase 2 |
| Terminated | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV NCT04893018 | Fred Hutchinson Cancer Center | Phase 1 |
| Unknown | Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV NCT06019273 | First Affiliated Hospital of Zhejiang University | — |
| Completed | A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candi NCT05208125 | IrsiCaixa | Phase 1 |
| Active Not Recruiting | Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO T NCT04265950 | Fred Hutchinson Cancer Center | Phase 4 |
| Completed | Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV NCT05154513 | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | — |
| Active Not Recruiting | Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in M NCT05074264 | University of California, San Francisco | N/A |
| Active Not Recruiting | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced NCT04514484 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Boston ARCH 4F Intervention to Reduce Fall Risk in People With HIV and Alcohol Use NCT04804579 | Boston University | N/A |
| Not Yet Recruiting | A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living NCT04914130 | Yonsei University | — |
| Completed | Incidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Bas NCT06629480 | Instituto Mexicano del Seguro Social | N/A |
| Completed | Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants W NCT04860323 | HIV Vaccine Trials Network | N/A |
| Active Not Recruiting | Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutrali NCT04340596 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed NCT05633927 | Hospitales Universitarios Virgen del Rocío | — |
| Completed | Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs) NCT01448915 | Johns Hopkins University | — |
| Completed | Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children NCT05085717 | Raincy Montfermeil Hospital Group | — |
| Withdrawn | Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell NCT04720742 | IrsiCaixa | Phase 2 |
| Terminated | Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals NCT04272242 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B NCT04193189 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Primary Resistance in HIV Patients in Colombia NCT03957369 | Fundacion REVIVA, Red de VIH del Valle del Cauca | — |
| Completed | Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy NCT04487145 | University of California, San Francisco | Phase 4 |
| Completed | Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial NCT04079218 | Kerry Murphy | Phase 4 |
| Completed | Functional Interval Training for Veterans Exercising Through Telehealth. NCT04103593 | VA Office of Research and Development | N/A |
| Unknown | Triple vs. Double Therapy in naïves HIV-Infected Patients NCT04295460 | Hospitales Universitarios Virgen del Rocío | Phase 4 |
| Completed | Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017) NCT04223778 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With NCT04223791 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Parti NCT04223804 | AbbVie | Phase 1 |
| Completed | Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America NCT04089488 | AIDS Malignancy Consortium | — |
| Completed | Bone Health and Vitamin D Status NCT01634607 | Thai Red Cross AIDS Research Centre | — |
| Completed | Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection NCT04042740 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 2 |
| Unknown | Study of Single IV Administration of P2G12 NCT02923999 | St George's, University of London | Phase 1 |
| Unknown | Antiretroviral Speed Access Program NCT04897243 | Dr. Bertrand Lebouche | — |
| Completed | HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV NCT03284866 | AIDS Malignancy Consortium | Phase 3 |
| Unknown | Role of the Balano-preputial Furrow 's Microbiota, in Circumcised Patients or Not, in the Acquisition or Trans NCT03985137 | Assistance Publique Hopitaux De Marseille | — |
| Completed | Dual bNAb Treatment in Children NCT03707977 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Sexual Risks in Prep Users NCT03975517 | University Hospital, Strasbourg, France | — |
| Completed | Nevirapine / Lamivudine for HIV Maintenance Therapy NCT07014189 | Cantonal Hospital of St. Gallen | Phase 4 |
| Terminated | HIV Reservoir Reduction With Interleukin-2 NCT03308786 | Case Western Reserve University | Phase 2 |
| Completed | Community Based Interventions to Improve HIV Outcomes in Youth: a Cluster Randomised Trial in Zimbabwe NCT03719521 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Enhanced Adherence Counselling, Pre-Post Study NCT04915469 | Elizabeth Glaser Pediatric AIDS Foundation | N/A |
| Terminated | Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) NCT03677960 | Antiva Biosciences | Phase 1 |
| Completed | Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer NCT03767465 | IrsiCaixa | — |
| Completed | Linking Infectious and Narcology Care-Part II NCT03290391 | Boston Medical Center | Phase 4 |
| Completed | St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene NCT03278886 | Boston Medical Center | Phase 1 / Phase 2 |
| Unknown | Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients NCT03941210 | ANRS, Emerging Infectious Diseases | — |
| Completed | Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women NCT02875119 | Population Council | Phase 1 |
| Completed | Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use NCT02744040 | Fred Hutchinson Cancer Center | N/A |
| Completed | Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) NCT03202992 | Antiva Biosciences | Phase 1 |
| Completed | Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV) NCT02797587 | Boston Medical Center | Phase 2 / Phase 3 |
| Completed | Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV NCT03976258 | MetroHealth Medical Center | — |
| Completed | TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru NCT02710032 | University of California, Los Angeles | N/A |
| Unknown | Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalen NCT03037372 | Makerere University | Phase 3 |
| Unknown | Genotyping FcɣRs Genes of HIV-1 Patients "Progressor": Correlation With the Changing Profile of the Infection NCT03130296 | University Hospital, Strasbourg, France | — |
| Unknown | RPV+DRV/Cobi Dual Therapy in Subjects With HIV Controlled Infection NCT04064632 | A.O. Ospedale Papa Giovanni XXIII | Phase 4 |
| Completed | Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions NCT03008941 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Phase 1 / Phase 2 |
| Completed | Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) NCT03145753 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | N/A |
| Completed | High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV NCT02841774 | Matthew Feinstein | Phase 2 |
| Completed | Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults NCT02960581 | International AIDS Vaccine Initiative | Phase 1 |
| Completed | ODYSSEY (PENTA 20) NCT02259127 | PENTA Foundation | Phase 2 / Phase 3 |
| Completed | Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings NCT02921516 | Florida International University | N/A |
| Terminated | Liraglutide for HIV-associated Neurocognitive Disorder NCT02743598 | Temple University | Phase 4 |
| Completed | Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles NCT02663869 | University of Modena and Reggio Emilia | — |
| Completed | Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda NCT02846402 | Harvard School of Public Health (HSPH) | N/A |
| Unknown | My Smart Age With HIV: Smartphone Self-assessment of Frailty NCT02663856 | University of Modena and Reggio Emilia | — |
| Completed | Metformin Immunotherapy in HIV Infection NCT02659306 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1 |
| Completed | Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immun NCT02886416 | ANRS, Emerging Infectious Diseases | — |
| Completed | Zambian Peer-Educators for HIV Self-Testing Study NCT02827240 | Harvard School of Public Health (HSPH) | N/A |
| Active Not Recruiting | Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Trans NCT02797470 | AIDS Malignancy Consortium | Phase 1 / Phase 2 |
| Withdrawn | Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma NCT02378922 | Fred Hutchinson Cancer Center | Phase 1 |
| Unknown | CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children) NCT02674867 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Child NCT02426112 | London School of Hygiene and Tropical Medicine | Phase 3 |
| Completed | Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Childre NCT02383108 | PENTA Foundation | Phase 2 / Phase 3 |
| Completed | Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 I NCT02767193 | Judit Pich Martínez | Phase 1 |
| Completed | ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment NCT02735863 | Abivax S.A. | Phase 2 |
| Completed | Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy NCT02471430 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Completed | Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medication NCT02595866 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural Lesotho NCT02692027 | Swiss Tropical & Public Health Institute | Phase 3 |
| Withdrawn | Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected Patients NCT03708861 | University of Turin, Italy | Phase 3 |
| Completed | Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in I NCT02148094 | University of Manitoba | EARLY_Phase 1 |
| Withdrawn | Improving Fibrosis Outcomes With Metformin NCT02306070 | Ottawa Hospital Research Institute | Phase 2 |
| Active Not Recruiting | Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma NCT01961063 | City of Hope Medical Center | Phase 1 |
| Completed | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin L NCT02059499 | AIDS Malignancy Consortium | Phase 3 |
| Unknown | Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide V NCT03041051 | Aghia Sophia Children's Hospital of Athens | Phase 4 |
| Active Not Recruiting | Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma NCT02337985 | City of Hope Medical Center | Phase 1 |
| Completed | Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients NCT02602262 | Johns Hopkins University | — |
| Completed | A Safety and Immunogenicity Trial of IHV01 NCT02756208 | University of Maryland, Baltimore | Phase 1 |
| Completed | Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression NCT02491242 | Asociacion para el Estudio de las Enfermedades Infecciosas | — |
| Terminated | Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lym NCT02408861 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for th NCT02405013 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Completed | Targeting Effective Analgesia in Clinics for HIV - Intervention NCT02564341 | Boston Medical Center | N/A |
| Completed | Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care NCT02938533 | University of California, Berkeley | N/A |
| Completed | Dual Therapy With Boosted Darunavir + Dolutegravir NCT02486133 | Technical University of Munich | Phase 3 |
| Completed | Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease NCT02339415 | Hennepin Healthcare Research Institute | Phase 2 |
| Withdrawn | Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma NCT02137564 | AIDS Malignancy Consortium | Phase 2 |
| Completed | Targeting Effective Analgesia in Clinics for HIV - Patient Cohort NCT02525731 | Boston Medical Center | — |
| Completed | The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infec NCT02473367 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Fostering Resilience to Psychosocial and HIV Risk in Indian MSM NCT02556294 | Massachusetts General Hospital | N/A |
| Completed | Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patien NCT02413645 | Judit Pich Martínez | Phase 1 |
| Completed | Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan NCT02626286 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients NCT02858414 | Centre Hospitalier Universitaire de Besancon | N/A |
| Active Not Recruiting | Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection NCT02437851 | AIDS Malignancy Consortium | Phase 2 |
| Completed | Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adoles NCT02426840 | Chiang Mai University | Phase 3 |
| Completed | Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Mon NCT02418494 | AIDS Malignancy Consortium | — |
| Completed | Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders NCT02936401 | University of California, San Francisco | N/A |
| Completed | Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP) NCT02067039 | Centers for Disease Control and Prevention | N/A |
| Completed | Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients NCT02384967 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Completed | IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence NCT02140944 | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | — |
| Completed | A Safety and Immune Response Study of 2 Experimental HIV Vaccines NCT02404311 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Recruiting | Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission NCT02140255 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | A Pilot Study of PrEP Acceptance Among Young Black MSM NCT02671591 | Richard Crosby | N/A |
| Completed | Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men NCT02287961 | ANRS, Emerging Infectious Diseases | N/A |
| Unknown | Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens NCT02411071 | University Hospital, Essen | — |
| Completed | Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure NCT02263326 | Babafemi Taiwo | Phase 3 |
| Completed | Glutathione and Function in HIV Patients NCT02348775 | Baylor College of Medicine | Phase 1 |
| Completed | Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women NCT02301507 | The University of Texas Health Science Center, Houston | N/A |
| Completed | A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients NCT02291081 | University Hospital, Essen | — |
| Completed | Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy NCT02199613 | University of British Columbia | Phase 4 |
| Unknown | Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Pati NCT02256579 | National Center for Global Health and Medicine, Japan | — |
| Completed | A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination NCT02362217 | University of Oxford | Phase 1 |
| Completed | Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions NCT02135419 | AIDS Malignancy Consortium | Phase 3 |
| Unknown | A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas NCT02302950 | The University of Texas Health Science Center, Houston | — |
| Completed | Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500 NCT02489487 | Viriom | Phase 1 |
| Completed | Lactoferrin Treatment in HIV Patients NCT01830595 | Jason Baker | Phase 2 |
| Terminated | Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir NCT01902186 | Giovanni Di Perri | Phase 4 |
| Completed | Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV NCT01852942 | University of Minnesota | Phase 2 |
| Completed | Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatme NCT02269605 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Phase 1 |
| Terminated | Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection NCT02109224 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Dipyridamole for Immune Activation in HIV NCT02121756 | Sharon Riddler | Phase 1 / Phase 2 |
| Completed | Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Re NCT02220868 | Saint Michael's Medical Center | Phase 4 |
| Terminated | Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surg NCT02134886 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtr NCT02159599 | Fundacion SEIMC-GESIDA | Phase 4 |
| Unknown | Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimb NCT02216734 | Family AIDS Caring Trust | N/A |
| Completed | The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia NCT02012816 | University of North Carolina, Chapel Hill | N/A |
| Completed | Immune Activation and Drug Absorption in HIV-Infected Patients NCT01845298 | Drexel University | N/A |
| Completed | Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination NCT02131233 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients NCT02093754 | ANRS, Emerging Infectious Diseases | N/A |
| Withdrawn | Dolutegravir + Rilpivirine Switch Study (DORISS) NCT02069834 | Nantes University Hospital | Phase 2 / Phase 3 |
| Completed | Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects NCT02154360 | University of Pennsylvania | Phase 1 |
| Completed | Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS NCT02140775 | New York State Psychiatric Institute | N/A |
| Completed | Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretrovira NCT02211807 | Bristol-Myers Squibb | — |
| Completed | Fish Oil for HIV-Related Inflamm-aging and Immune Senescence NCT02102724 | Rush University Medical Center | N/A |
| Completed | Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men NCT02019771 | University of Nebraska | — |
| Completed | Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers NCT02038842 | ANRS, Emerging Infectious Diseases | Phase 1 / Phase 2 |
| Completed | Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection NCT01900015 | Juan Macías | Phase 4 |
| Completed | Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Supp NCT01905059 | ANRS, Emerging Infectious Diseases | Phase 3 |
| Completed | Trial of Vitamin D in HIV Progression NCT01798680 | Harvard School of Public Health (HSPH) | Phase 3 |
| Completed | Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection NCT01147107 | University of Hawaii | Phase 4 |
| Completed | Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmac NCT02034838 | Ottawa Hospital Research Institute | Phase 1 |
| Completed | Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV NCT01946139 | AIDS Malignancy Consortium | N/A |
| Completed | EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients NCT01886404 | University of Nebraska | — |
| Completed | Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance NCT01746199 | Institut Pasteur | Phase 3 |
| Completed | Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administ NCT01993706 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells NCT01900106 | University of Modena and Reggio Emilia | Phase 3 |
| Completed | X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study NCT01952587 | ANRS, Emerging Infectious Diseases | N/A |
| Terminated | Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection NCT01249443 | AIDS Malignancy Consortium | Phase 1 |
| Completed | Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort NCT01934803 | Boston Medical Center | N/A |
| Completed | Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS NCT02118168 | Barbara Ensoli, MD, PhD | — |
| Completed | Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials NCT01946217 | AIDS Malignancy Consortium | — |
| Completed | Text Messaging to Improve HIV Testing Among Young Women in Kenya NCT02527135 | University of Washington | N/A |
| Completed | Birmingham Access to Care Study NCT02525146 | University of Alabama at Birmingham | N/A |
| Active Not Recruiting | Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men NCT02816879 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Asha Improving Health and Nutrition of Indian Women With AIDS and Their Children NCT02136082 | University of California, Los Angeles | N/A |
| Terminated | Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV NCT01601626 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 2 |
| Completed | Trial of Ibudilast for Methamphetamine Dependence NCT01860807 | University of California, Los Angeles | Phase 2 |
| Completed | Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients NCT01899196 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus NCT01822522 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults NCT02109354 | HIV Vaccine Trials Network | Phase 1 |
| Completed | A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc NCT01894776 | Ottawa Hospital Research Institute | Phase 1 |
| Completed | Factors Affecting PrEP Adherence NCT02411630 | University of North Carolina, Chapel Hill | — |
| Completed | Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin NCT01771107 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Y NCT01769456 | University of North Carolina, Chapel Hill | Phase 2 |
| Unknown | Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa NCT02025868 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Completed | Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of NCT02485509 | Viriom | Phase 1 / Phase 2 |
| Terminated | Pilot Study of Diflunisal in HIV-infected Adults NCT01676363 | University of British Columbia | Phase 4 |
| Completed | Feasibility of Using a Structured Daily Diary NCT01953653 | University of North Carolina, Chapel Hill | N/A |
| Completed | Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? NCT01895920 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication NCT01865786 | Gilead Sciences | — |
| Completed | Clinical Trial to Reduce Drinking in Women With HIV NCT01625091 | University of Florida | Phase 3 |
| Completed | Use of Incentives to Retain Drug Users in HIV Therapy NCT01488942 | University of British Columbia | N/A |
| Completed | Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B NCT02054286 | Theravectys S.A. | Phase 1 / Phase 2 |
| Completed | Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir NCT01818856 | Hospitales Universitarios Virgen del Rocío | Phase 1 |
| Completed | A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With NCT01717287 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Partners Demonstration Project of PrEP and ART NCT02775929 | University of Washington | Phase 4 |
| Completed | Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort NCT01614626 | Boston Medical Center | — |
| Completed | Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort NCT01740115 | Boston Medical Center | — |
| Completed | Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM) NCT01769469 | University of North Carolina, Chapel Hill | — |
| Completed | An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis NCT01772823 | University of North Carolina, Chapel Hill | Phase 2 |
| Completed | Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotypin NCT01823614 | Dmitry Kireev | — |
| Completed | Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART NCT01751646 | University of North Carolina, Chapel Hill | N/A |
| Completed | The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling NCT01843478 | Johns Hopkins University | N/A |
| Completed | Folinic Acid: Supplementation and Therapy NCT02810275 | Hospital de Clinicas de Porto Alegre | Phase 3 |
| Completed | Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations NCT01686750 | Johns Hopkins University | N/A |
| Unknown | Neural Correlates of Working Memory Training for HIV Patients NCT02602418 | University of Hawaii | N/A |
| Completed | Immune Reconstitution in HIV Disease (IREHIV) NCT01702974 | Karolinska Institutet | Phase 2 |
| Completed | Antiretroviral Therapy and Extreme Weight NCT01805427 | Hopital Lariboisière | — |
| Completed | Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART NCT01680094 | University of Aarhus | Phase 1 / Phase 2 |
| Completed | Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunte NCT02489435 | Viriom | Phase 1 |
| Completed | Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study NCT01679964 | Lin, Hsi-Hsun, M.D. | Phase 4 |
| Completed | Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + NCT01576731 | Hospital Clinic of Barcelona | Phase 4 |
| Completed | Linking Infectious and Narcology Care in Russia NCT01612455 | Boston Medical Center | N/A |
| Completed | Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients NCT02934022 | Southern California Institute for Research and Education | N/A |
| Completed | Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Pre NCT01505114 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Testing and Linkage to Care for Injecting Drug Users in Kenya NCT01557998 | Yale University | N/A |
| Completed | HIV Disclosure and Medication Adherence, a Pilot Study NCT01621412 | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | — |
| Completed | Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence NCT01509508 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX NCT01629316 | University of North Carolina, Chapel Hill | N/A |
| Completed | Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women NCT01621347 | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | — |
| Unknown | Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection NCT01529073 | Juan Macías | Phase 2 |
| Recruiting | the ANRS CO21 " Extreme " Cohort (CODEX) NCT01520844 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | Use of Incentives to Engage Drug Users in HIV Therapy NCT01526421 | University of British Columbia | N/A |
| Completed | Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICI NCT01533272 | Hospital Clinic of Barcelona | Phase 4 |
| Completed | Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France NCT02566148 | ANRS, Emerging Infectious Diseases | — |
| Terminated | Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy NCT01728961 | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Phase 4 |
| Completed | Early Antiviral Therapy for Critically Ill HIV Infected Patients NCT01455688 | Hospital Nossa Senhora da Conceicao | Phase 4 |
| Completed | Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV NCT01407237 | Massachusetts General Hospital | — |
| Completed | Evaluation of Barriers to Postpartum Care in HIV Infected Women NCT01853917 | The University of Texas Health Science Center, Houston | — |
| Completed | On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men NCT01473472 | ANRS, Emerging Infectious Diseases | Phase 3 |
| Unknown | RAltegravir Switch STudy: Effects on Endothelial Recovery NCT01453933 | UMC Utrecht | Phase 4 |
| Completed | Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in NCT02123433 | University of Siena | Phase 3 |
| Withdrawn | Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents NCT01492803 | University of North Carolina, Chapel Hill | N/A |
| Completed | Atazanavir/Ritonavir and Zinc Pharmacokinetic Study NCT01475227 | St Stephens Aids Trust | Phase 4 |
| Completed | Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs NCT01543035 | Calmy Alexandra | Phase 3 |
| Completed | Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention NCT01752504 | University of North Carolina, Chapel Hill | N/A |
| Completed | Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant NCT01473810 | Oslo University Hospital | Phase 1 / Phase 2 |
| Completed | Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment NCT01433796 | Lund University | — |
| Completed | Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patient NCT01471821 | Juan A. Arnaiz | Phase 4 |
| Completed | REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment NCT01380080 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 4 |
| Completed | Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women NCT01125371 | Johns Hopkins University | N/A |
| Completed | Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract NCT01456962 | University of Colorado, Denver | — |
| Completed | The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1 NCT01451333 | Kirby Institute | Phase 3 |
| Terminated | A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Protein NCT01441193 | Barbara Ensoli, MD | Phase 1 |
| Completed | The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK) NCT01271894 | Kirby Institute | Phase 3 |
| Completed | Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired H NCT01492842 | University of North Carolina, Chapel Hill | — |
| Completed | A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Trea NCT01571466 | Hospital Clinic of Barcelona | Phase 1 |
| Completed | Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy NCT01307488 | Fundacion SEIMC-GESIDA | Phase 4 |
| Terminated | Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors NCT01474954 | University of California, San Francisco | — |
| Completed | A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV NCT01362634 | Nova Southeastern University | N/A |
| Completed | Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining NCT01417949 | Universitätsklinikum Hamburg-Eppendorf | Phase 4 |
| Completed | Enhancement of Connect to Protect® (C2P) NCT01492816 | University of North Carolina, Chapel Hill | N/A |
| Terminated | Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment NCT01417988 | Prof JMA Lange | Phase 4 |
| Completed | Residual Risk Assessment Of HIV Transmission NCT01413152 | French National Agency for Research on AIDS and Viral Hepatitis | N/A |
| Completed | Switch to Unboosted Atazanavir With Tenofovir Study NCT01351740 | University of British Columbia | Phase 4 |
| Recruiting | Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais NCT01397669 | SEARCH Research Foundation | N/A |
| Completed | The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Imm NCT01426243 | French National Agency for Research on AIDS and Viral Hepatitis | Phase 3 |
| Completed | Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to NCT01389310 | Bristol-Myers Squibb | — |
| Completed | An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana NCT01836003 | Harvard School of Public Health (HSPH) | N/A |
| Completed | Study on Immunopathogenesis in HIV and Hepatitis C Coinfection NCT01296529 | Rush University Medical Center | — |
| Completed | Improving Antiretroviral Medication Adherence Among HIV-infected Youth NCT01347437 | Fenway Community Health | N/A |
| Unknown | Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men NCT01300689 | Chinese Academy of Medical Sciences | — |
| Terminated | Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA) NCT01367210 | Catholic University of the Sacred Heart | Phase 4 |